Spearhead Capital Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.6M | Sell |
202,580
-32,444
| -14% | -$417K | 2.82% | 5 |
|
|
2022
Q2 | $2.28M | Hold |
235,024
| – | – | 0.34% | 54 |
|
|
2022
Q1 | $2.34M | Hold |
235,024
| – | – | 0.29% | 56 |
|
|
2021
Q4 | $2.77M | Hold |
235,024
| – | – | 0.33% | 56 |
|
|
2021
Q3 | $2.68M | Hold |
235,024
| – | – | 0.36% | 52 |
|
|
2021
Q2 | $3.27M | Sell |
235,024
-141,821
| -38% | -$1.98M | 0.45% | 56 |
|
|
2021
Q1 | $6.98M | Buy |
376,845
+106,728
| +40% | +$1.98M | 1.03% | 55 |
|
|
2020
Q4 | $4.77M | Hold |
270,117
| – | – | 0.76% | 56 |
|
|
2020
Q3 | $4.14M | Sell |
270,117
-678
| -0.3% | -$10.4K | 0.79% | 56 |
|
|
2020
Q2 | $6.9M | Hold |
270,795
| – | – | 1.47% | 17 |
|
|
2020
Q1 | $4.19M | Buy |
+270,795
| New | +$4.19M | 1.21% | 44 |
|